DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hislop J, Mowatt G, Sharma P et al.
Systematic review of escalated imatinib doses compared with sunitinib or best supportive care, for the treatment of people with unresectable / metastatic gastrointestinal stromal tumours whose disease has progressed on the standard imatinib dose.
J Gastrointest Cancer 2012;
43: 168-176
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.